Pdt Partners, LLC Ionis Pharmaceuticals Inc Transaction History

Pdt Partners, LLC

$981 Million
Q2 2024

A detailed history of Pdt Partners, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Pdt Partners, LLC holds 13,430 shares of IONS stock, worth $533,305. This represents 0.07% of its overall portfolio holdings.

Number of Shares

13,430

Holding current value

$533,305

% of portfolio

0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$36.45 - $47.7 $489,523 - $640,611	13,430 New	13,430 $640,000
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $40,001 - $48,968	1,039 Added 5.62%	19,537 $886,000
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $642,435 - $801,518	18,498 New	18,498 $758,000
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $640,700 - $868,815	-20,205 Reduced 25.23%	59,865 $2.22 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $369,705 - $458,295	12,373 Added 18.28%	80,070 $2.97 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $1.73 Million - $2.38 Million	67,697 New	67,697 $2.06 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $4.76 Million - $5.76 Million	-141,925 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $4.9 Million - $6.71 Million	141,925 New	141,925 $5.66 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $4.76 Million - $7.15 Million	-112,045 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $432,026 - $574,794	-9,537 Reduced 7.84%	112,045 $6.34 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $250,630 - $332,501	5,282 Added 4.54%	121,582 $5.77 Million
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $5.45 Million - $7.1 Million	116,300 New	116,300 $6.86 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $21.2 Million - $29.4 Million	-341,800 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $2.62 Million - $4.02 Million	-49,500 Reduced 12.65%	341,800 $27.7 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $1,604 - $2,202	-37 Reduced 0.01%	391,300 $21.2 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $1,586 - $1,986	37 Added 0.01%	391,337 $20.2 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $1.22 Million - $1.53 Million	30,100 Added 8.33%	391,300 $16.3 Million
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $1.99 Million - $2.49 Million	-45,161 Reduced 11.11%	361,200 $15.9 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $933,014 - $1.19 Million	-18,549 Reduced 4.37%	406,361 $20.4 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $19.4 Million - $25.3 Million	424,910	424,910 $21.5 Million

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

Vanguard Group Inc Valley Forge, PA

13.8M
Shares

$550 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

12.6M
Shares

$502 Million
0.38% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$410 Million
0.01% of portfolio
Bellevue Group Ag Kuesnacht, V8

8.26M
Shares

$328 Million
6.59% of portfolio
Wellington Management Group LLP Boston, MA

6.57M
Shares

$261 Million
0.06% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account